International regenerative medicine groups form strategic alliance to commercialise cell therapies / Publication

The Cooperative Research Centre for Cell Therapy Manufacturing (CTM CRC) has formed a strategic alliance with two international regenerative medicine translation centres, the Centre for Commercialization of Regenerative Medicine (CCRM) in Canada and the Cell Therapy Catapult in the UK. The alliance will provide CTM CRC, CCRM and the Cell Therapy Catapult a pathway for collaboration to further drive the development and commercialisation of cell therapies on a global level

Read More

Insights into cellular uptake of nanoparticles / Publication

Abstract: Nanomaterials promise to improve disease diagnosis and treatment by enhancing the delivery of drugs, genes, biomolecules and imaging agents to specific subcellular targets. In order to optimize nanomaterial design for this purpose, a comprehensive understanding of how these materials are taken up and transported within the cell is required.

Read More